RxPerts Academy

Knowledge for the Next Era of Healthcare

RxPerts Academy

White Paper

Learn more about the issue of polypharmacy and how payers can help address it, including:  Differing definitions of polypharmacy and the “Holy Trinity” interaction of CNS-affecting drugs 

View White Paper
Blog Post

Returning from The American Pharmacists Association’s (APhA) recent Annual Meeting & Exposition in Seattle, WA, I feel invigorated and excited about what is happening in our natio...

View Blog Post
Blog Post

Throughout life, genomes are stable, but gene expression and their function may vary as we age. The biggest challenge to clinicians is gene expression and ontogeny in children. Understanding pediatric ...

View Blog Post
Blog Post

In a major prospective National Institutes of Health (NIH)-funded study known as the VITAL trial, omega-3 fatty acid supplementation did not result in a lower incide...

View Blog Post
Blog Post

A major prospective National Institutes of Health (NIH)-funded trial known as the VITAL trial involved 25,871 participants from the general population in order to de...

View Blog Post
Blog Post

It’s that time again. The American Geriatrics Society (AGS) Beers Criteria® were updated recently, as they are every three years, by an interdis...

View Blog Post
Blog Post

The Center for Medicare and Medicaid Services (CMS) Office of the Actuary released its nationa...

View Blog Post
Webinar

Eric Henry, Clinical Content Specialist focused on the domestic drug file with Clinical Effectiveness at Wolters Kluwer, Heath, in a 45-minute live webinar to discuss:  The potential impact of biosimilars...

View Webinar
Webinar

Brent I. Fox, Auburn University health IT expert, in a 45-minute live webinar to discuss:  Prevailing trends in healthcare in 2019 and beyond  Effect of these trends on pharmacy practice&n...

View Webinar

Pages

Become an RxPerts Insider

Sign up to receive the latest news and information!

Sign Up